ATP7B Recombinant Monoclonal Antibody

說明書

中文名稱：

ATP7B重組抗體
貨號：

CSB-RA002415MA1HU
規格：

￥1320
圖片：
Immunofluorescence staining of Hela cell with CSB-RA002415MA1HU at 1:100, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 488-congugated AffiniPure Goat Anti-Rabbit IgG(H+L).

Overlay Peak curve showing Hela cells stained with CSB-RA002415MA1HU (red line) at 1:100. The cells were fixed in 4% formaldehyde (15min) and permeated by 0.2% TritonX-100 for 10min. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10⁶cells) for 45min at 4℃. The secondary antibody used was FITC-conjugated Goat Anti-Rabbit IgG(H+L) at 1/200 dilution for 35 min at 4°C. Isotype control antibody (green line) was mouse IgG1 (1μg/1*10⁶cells) used under the same conditions. Acquisition of >10,000 events was performed.
其他：

產品詳情
產品評價
相關產品
靶點詳情

產品詳情

產品描述：

ATP7B Recombinant Monoclonal Antibody（CSB-RA002415MA1HU）是針對銅轉運關鍵蛋白ATP7B研發的高特異性檢測工具。ATP7B是一種銅離子轉運P型ATP酶，主要分布于肝臟和高爾基體，負責細胞內銅離子的跨膜運輸及銅藍蛋白的金屬化修飾，其功能缺陷與威爾遜病的發生密切相關。本抗體經ELISA、免疫熒光（IF）和流式細胞術（FC）嚴格驗證，在推薦稀釋比例（IF：1:50-1:200；FC：1:50-1:200）下表現出優異的目標蛋白結合能力，可清晰顯示ATP7B的亞細胞定位特征。該產品適用于探索銅代謝調控網絡、研究ATP7B在肝膽系統病理生理過程中的作用機制，或分析金屬離子穩態相關信號通路等科研場景，為疾病模型構建、蛋白質互作研究及藥物靶點篩選提供可靠工具。采用重組單克隆抗體技術制備，具備高批次一致性和低交叉反應性，滿足復雜實驗體系中對檢測穩定性的嚴苛要求。
Uniprot No.：

P35670
基因名：

ATP7B
別名：

ATP7B antibody; ATP7B_HUMAN antibody; ATPase, Cu(2+) transporting, beta polypeptide antibody; ATPase, Cu++ transporting, beta polypeptide antibody; Copper pump 2 antibody; Copper transporting ATPase 2 antibody; PWD antibody; Toxic milk antibody; tx antibody; WC1 antibody; WD antibody; Wilson disease associated protein antibody; Wilson disease-associated protein antibody; WND antibody; WND/140 kDa antibody
反應種屬：

Human
免疫原：

Recombinant Human ATP7B protein
免疫原種屬：

Homo sapiens (Human)
標記方式：

Non-conjugated
克隆類型：

Monoclonal
抗體亞型：

Rabbit IgG
純化方式：

Affinity-chromatography
克隆號：

24A4
濃度：

It differs from different batches. Please contact us to confirm it.
保存緩沖液：

Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
產品提供形式：

Liquid
應用范圍：

ELISA, IF, FC

推薦稀釋比：

Application	Recommended Dilution
IF	1:20-1:200
FC	1:20-1:200

Protocols：

ELISA Protocol
Immunofluorescence (IF) Protocol
Flow cytometry (FC) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

功能：

Copper ion transmembrane transporter involved in the export of copper out of the cells. It is involved in copper homeostasis in the liver, where it ensures the efflux of copper from hepatocytes into the bile in response to copper overload.
基因功能參考文獻：
1. Study reports the NMR structure of the metal-binding domain 1 (MBD1) of ATP7B. The structure reveals the disruptive mechanism of G85V mutation, one of the very few Singular Wilson disease causing missense mutations in the MBD1-4 region of ATP7B. The protein misfolding will disrupt MBD1-3 interactions, and interfere with proper ATP7B trafficking and activity which, in turn may be followed by protein degradation. PMID: 29330485
2. Single-particle analysis yielded a low-resolution 3D model that provides the first insight into an overall architecture of human ATP7B, positions of the main domains, and a dimer interface. PMID: 28842499
3. The genotypes of ATP7B gene may be novel and significant biomarkers for predicting the gastrointestinal toxicity of platinum-based chemotherapy in NSCLC patients. PMID: 29970670
4. The ATP7B gene codes the ATP7B protein, which is an acronym for: ATPase activity, 7 distinct domain, and B class for second P-type ATPase copper binding pump. PMID: 29540233
5. Mutations in the alpha-1-antitrypsin and Wilson's genes may act as cofactors in the pathogenesis of fatty liver diseases. PMID: 29324588
6. Compound heterozygous mutations Arg778Leu and a variant in intron4:c.1707 + 5G>A were identified in a case of Wilson's disease with adrenocortical insufficiency. c.1707 + 5G>A variant resulted in exon 4 skipping. PMID: 29181760
7. These findings were different from previous studies in Asia. Our research established a suitable strategy for ATP7B gene testing in northern Vietnamese WD patients. PMID: 29321352
8. Wilson disease (WD) is an autosomal-recessive disease caused by mutations in the ATP7B gene which encodes a copper-transporting ATPase. PMID: 29325617
9. The role of metal-binding domains in ATP7B function and Wilson disease causing point mutations.[review] PMID: 29063292
10. for ATP7B mutations, the more severe impact on ATP7B protein was, the younger onset age and lower Cp level presented. The feasibility of presymptomatic DNA diagnosis and predicting clinical manifestation or severity of Wilson disease (WD) would be facilitated with identified mutations and genotype-phenotype correlation precisely revealed in the study. PMID: 27982432
11. Among those >800 reported mutations of the ATP7B gene missense/nonsense mutations are very rare. A874V-ATP7B protein mutant showed apparent destabilization and endoplasmic reticulum retention, and lost copper transport activity, thus likely causing Wilson disease phenotype. PMID: 29381936
12. Our findings imply that reduced stability and enhanced dynamics of MBD1 or MBD6 is the origin of ATP7B dysfunction in Wilson disease patients with the G85V or G591D mutation. PMID: 27744583
13. single nucleotide polymorphisms in ATP7B gene is associated with copper dysmetabolism in Alzheimer's disease. PMID: 27499330
14. Mutation in ATP7B gene is associated with copper dysmetabolism in Wilson disease. PMID: 27714068
15. We here demonstrate that ATP7B confers multidrug resistance by facilitating nuclear drug efflux and late endosomal drug sequestration. PMID: 26988911
16. Wilson's disease results from mutations that cause absent or markedly diminished levels of ATP7B that can be determined in dried blood spots using a novel immune-SRM assay. PMID: 27935710
17. Expression of the most frequent ATP7B mutant, H1069Q, activates p38 and c-Jun N-terminal kinase signaling pathways, which favor the rapid degradation of the mutant. PMID: 26660341
18. Results reveal that partial gene deletions in ATP7B represent causative mutations in some of the uncharacterized Wilson's disease alleles. PMID: 27992490
19. Stratified analysis by genotypes revealed that both outdoor and indoor copper exposure increased inattentiveness in ATP7B rs1061472-CC and rs1801243-CC carriers. PMID: 28008856
20. ATP7B mutant cell lines showed different degrees of cell survival and characteristic responses upon treatment with Zn and D-penicillamine. PMID: 27122662
21. Five of the nineteen mutations in ATP7B were newly detected mutations; moreover, 8 of these mutations were polymorphic (2 were newly identified). PMID: 27706781
22. miR-133a enhances the sensitivity of multidrug-resistant epithelial cells to cisplatin by downregulating ATP7B expression. PMID: 27121102
23. the identification of novel mutations in ATP7B for Wilson disease and hereditary hemochromatosis (HFE) or the non-HFE genes for HH has increased, especially with the application of whole genome sequencing technology in recent years, the biological function of the identified mutations, as well as genotype-phenotype correlations remain to be explored PMID: 27592149
24. In the group of 75 Wilson Disease patients of Croatian origin, 18 different mutations in ATP7B gene were detected, three of which were novel. The p.His1069Gln mutation was most frequent, being detected in 44 Croatian WD patients (58.7%). Most ATP7B mutations (90.4%) were located in exons 5, 8, 13, 14, and 15. PMID: 26799313
25. 24 ATP7B distinct mutations, seven of which are novel, have been found in 35 patients with hepatolenticular degeneration. PMID: 26782526
26. With the capability of generating relatively higher throughput in a short time period, the NGS assay is a viable alternative to Sanger sequencing for detecting ATP7B mutations causally linked to Wilson disease in the clinical diagnostic laboratory PMID: 26483271
27. analysis of the geographic distribution of ATP7B mutations in Wilson disease [review] PMID: 26207595
28. Extrinsic expressing WT ATP7B reduced CuCl2-induced copper accumulation and enhanced cellular copper tolerance by accelerating copper excretion, which was selectively compromised by R778L and P992L mutations. PMID: 26032686
29. Metal-dependent movement of the first four metal-binding domains in ATP7B may be a trigger that initiates the overall catalytic cycle. PMID: 26797276
30. Nine out of the thirty-two pediatric Turkish WD patients had no mutations in the ATP7B gene. PMID: 26215059
31. Novel mutation of the ATP7B gene was found in Chinese families with pre-symptomatic Wilson's disease. PMID: 26253413
32. 7 novel mutations, c.3871G>A(p.A1291T), c.2593_2594insGTCA, c.2790_2792delCAT, c.3661_3663delGGG, c.3700delG, c.4094_4097delCTGT, and IVS6+1G>A, are associated with Wilson's disease. PMID: 26829729
33. Wilson disease causing p.T788I, p.V1036I and p.R1038G-fsX83 mutations lead to functional deficiency in ATP7B protein. PMID: 26004889
34. The present results demonstrate the design and evaluation of a low-density microarray for the detection of 62 mutations in ATP7B gene, and show that a microarray based approach can be cost-effective for detecting a large number of mutations simultaneously PMID: 25900953
35. Screening for the two exons 14 and 18 of the ATP7B gene is important in Egyptian patients especially in suspected patients without hepatic manifestations. PMID: 25465132
36. The ATP7B gene testing for the boy, his sister, and their parents detected two novel missense mutations in the boy and his sister, i.e., compound heterozygous mutations in exon 7 and exon 13 PMID: 26182283
37. Most frequent mutation c.3402delC (p.Ala1135GlnfsX13) among Wilson disease patients in Venezuela has a wide distribution and two old origins PMID: 25497208
38. The detection of new mutations in the ATP7B gene can aid in genetic counseling and clinical or/prenatal diagnosis. PMID: 25982861
39. Identification of mutations and polymorphisms of the ATP7B gene which may contribute to the pathogenesis of Wilson disease. PMID: 24878384
40. association between the c.2299insC mutation and hepatic phenotype and between the p. Ala1003Thr mutation and neurologic phenotype in Wilson disease in a large Lebanese family PMID: 25390358
41. The purpose of this study was to determine a haplotype analysis of two unrelated Wilson disease patients with the same missense mutation PMID: 25365615
42. showed that hyperphosphorylation occurs even when ATP7B is restricted to the trans-Golgi network PMID: 25666620
43. Wilson disease patients with the splice-site mutation show severe clinical manifestations, indicating that aberrant transcripts have important implications for Wilson disease phenotype. PMID: 25086856
44. Study identifies three novel mutations in ATP7B, confirms Arg778Leu as the most frequent mutation in Chinese Wilson's disease (WD) patients, and demonstrates that Ile1148Thr was another hotspot mutation in WD patients from Southern China PMID: 25089800
45. Data show that nanobodies detected transient interactions between the metal-binding domains (MBDs) and modulated intracellular localization of Cu(I)-ATPase ATP7B. PMID: 25253690
46. The functional survey of amino acid changes in the ATP7B protein is provided herein, and this bioinformatic method can furnish information about novel ATP7B mutations. Furthermore, the same approach can be applied to other uncharacterized proteins. PMID: 24253677
47. ATP7B gene might be considered as predictive markers for the efficacy evaluation of platinum-based chemotherapy in Chinese Han lung cancer patients PMID: 24852429
48. different coding mutations were detected in our patient pool including 21 novel and 37 reported variants in Indian patients with Wilson disease PMID: 24094725
49. revealed an unexpected role for TM1/TM2 in copper-regulated trafficking of ATP7B and defined a unique class of WD mutants that are transport-competent but trafficking-defective PMID: 24706876
50. Individuals who were GG homozygous for ATP7B rs7323774 SNP had higher levels of serum-free copper, and this condition was more pronounced in the AD individuals. PMID: 23760784
顯示更多

收起更多
相關疾病：

Wilson disease (WD)
亞細胞定位：

Golgi apparatus, trans-Golgi network membrane; Multi-pass membrane protein. Late endosome.; [Isoform 1]: Golgi apparatus membrane; Multi-pass membrane protein.; [Isoform 2]: Cytoplasm.; [WND/140 kDa]: Mitochondrion.
蛋白家族：

Cation transport ATPase (P-type) (TC 3.A.3) family, Type IB subfamily
組織特異性：

Most abundant in liver and kidney and also found in brain. Isoform 2 is expressed in brain but not in liver. The cleaved form WND/140 kDa is found in liver cell lines and other tissues.
數據庫鏈接：

HGNC: 870

OMIM: 277900

KEGG: hsa:540

STRING: 9606.ENSP00000242839

UniGene: Hs.492280

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human